Morgan Stanley Downgrades HCP to Underweight

Brokerage firm Morgan Stanley Downgrades its rating on HCP(NYSE:HCP). The shares have been rated Underweight. Previously, the analysts had a Equal-weight rating on the shares. The rating by Morgan Stanley was issued on Jun 22, 2016.

In a different note, On May 16, 2016, Citigroup said it Maintains its rating on HCP. In the research note, the firm Raises the price-target to $31.00 per share. The shares have been rated ‘Neutral’ by the firm. On May 10, 2016, Jefferies said it Upgrades its rating on HCP. In the research note, the firm Raises the price-target to $25.00 per share. The shares have been rated ‘Hold’ by the firm. On Apr 1, 2016, Citigroup said it Maintains its rating on HCP. In the research note, the firm Raises the price-target to $27.50 per share. The shares have been rated ‘Neutral’ by the firm.

HCP (HCP) shares turned negative on Mondays trading session with the shares closing down -0.05 points or -0.15% at a volume of 46,99,600. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $34.315. The peak price level was also seen at $34.315 while the days lowest was $33.6. Finally the shares closed at $34.18. The 52-week high of the shares is $40.9 while the 52-week low is $25.1104. According to the latest information available, the market cap of the company is $15,965 M.

HCP(HCP) last announced its earnings results on May 9, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $640.78M. Analysts had an estimated revenue of $621.93M. Earnings per share were $0.69. Analysts had estimated an EPS of $0.69.

Several Insider Transactions has been reported to the SEC. On May 11, 2016, Kai Hsiao (Executive Vice President) sold 266 shares at $36.04 per share price.Also, On Feb 17, 2016, John D. Stasinos (Executive Vice President) purchased 400 shares at $26.24 per share price.On Feb 16, 2016, Troy E. Mchenry (EVP, Gen Counsel and Corp Sec) purchased 1,000 shares at $25.75 per share price, according to the Form-4 filing with the securities and exchange commission.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *